ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving ILUVIEN ® (fluocinolone acetonide intravitreal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results